Skip to main content

Main menu

  • Home
  • Current issue
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • COVID-19 submission information
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • COVID-19 submission information
    • Institutional open access agreements
    • Peer reviewer login
  • Alerts
  • Subscriptions

The need to move from 6-minute walk distance to outcome trials in pulmonary arterial hypertension

Sean Gaine, Gérald Simonneau
European Respiratory Review 2013 22: 487-494; DOI: 10.1183/09059180.00006213
Sean Gaine
1National Pulmonary Hypertension Unit, Mater Misericordiae University Hospital, Dublin, Ireland. 2Service de Pneumologie, Hôpital Universitaire de Bicêtre, Université Paris-Sud, Le Kremlin Bicêtre, France.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: sgaine@mater.ie
Gérald Simonneau
1National Pulmonary Hypertension Unit, Mater Misericordiae University Hospital, Dublin, Ireland. 2Service de Pneumologie, Hôpital Universitaire de Bicêtre, Université Paris-Sud, Le Kremlin Bicêtre, France.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 22 no. 130 487-494
DOI 
https://doi.org/10.1183/09059180.00006213
PubMed 
24293464

Published By 
European Respiratory Society
Print ISSN 
0905-9180
Online ISSN 
1600-0617
History 
  • Received August 30, 2013
  • Accepted September 29, 2013
  • Published online November 29, 2013.

Copyright & Usage 
©ERS 2013 ERR articles are open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 3.0.

Author Information

  1. Sean Gaine1⇑ and
  2. Gérald Simonneau2
  1. 1National Pulmonary Hypertension Unit, Mater Misericordiae University Hospital, Dublin, Ireland. 2Service de Pneumologie, Hôpital Universitaire de Bicêtre, Université Paris-Sud, Le Kremlin Bicêtre, France.
  1. S. Gaine, National Pulmonary Hypertension Unit, Mater Misericordiae Hospital, Eccles Street, Dublin 7, Ireland. E-mail: sgaine{at}mater.ie
View Full Text

Article usage

Article usage: November 2013 to February 2023

AbstractFullPdf
Nov 2013131421
Dec 2013886108216
Jan 201452294109
Feb 20144034856
Mar 20141646355
Apr 20141696547
May 20141135226
Jun 2014793314
Jul 2014764926
Aug 2014553825
Sep 2014945431
Oct 2014945241
Nov 2014755744
Dec 2014473730
Jan 2015512818
Feb 2015335225
Mar 2015534621
Apr 2015473921
May 2015384022
Jun 2015354318
Jul 2015345117
Aug 2015444726
Sep 2015255134
Oct 201575715
Nov 201526014
Dec 201524414
Jan 201684829
Feb 201603113
Mar 2016157326
Apr 201695835
May 201624220
Jun 201633917
Jul 201636025
Aug 201613514
Sep 2016225426
Oct 2016345423
Nov 2016175211
Dec 2016125621
Jan 2017107818
Feb 201797317
Mar 201755815
Apr 2017153510
May 201765111
Jun 201794911
Jul 201765517
Aug 201756619
Sep 201747714
Oct 201769820
Nov 2017119723
Dec 201751399
Jan 2018926917
Feb 2018718810
Mar 2018618614
Apr 2018715212
May 2018518814
Jun 2018420710
Jul 20181913611
Aug 2018220411
Sep 201821788
Oct 201852457
Nov 2018327219
Dec 2018419613
Jan 2019712717
Feb 201920919
Mar 2019928015
Apr 20191184512
May 2019974813
Jun 2019505718
Jul 20191285510
Aug 20192146111
Sep 2019220628
Oct 20192217211
Nov 20191426110
Dec 2019824813
Jan 20202657
Feb 20201446
Mar 202014113
Apr 202015617
May 202035216
Jun 202015914
Jul 202024710
Aug 202014510
Sep 202027019
Oct 202036310
Nov 202015416
Dec 202036117
Jan 202105516
Feb 202125513
Mar 2021126419
Apr 202147522
May 202116224
Jun 202124829
Jul 202133413
Aug 202124827
Sep 20210319
Oct 202125333
Nov 202136329
Dec 202124213
Jan 202215610
Feb 202256530
Mar 202226725
Apr 202226217
May 202236131
Jun 202213626
Jul 202225017
Aug 202213615
Sep 202205324
Oct 202275833
Nov 20223296
Dec 20221278
Jan 202302310
Feb 20233536

Altmetrics

PreviousNext
Back to top
View this article with LENS
Vol 22 Issue 130 Table of Contents
  • Table of Contents
  • Table of Contents (PDF)
  • Cover (PDF)
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
The need to move from 6-minute walk distance to outcome trials in pulmonary arterial hypertension
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
The need to move from 6-minute walk distance to outcome trials in pulmonary arterial hypertension
Sean Gaine, Gérald Simonneau
European Respiratory Review Dec 2013, 22 (130) 487-494; DOI: 10.1183/09059180.00006213

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
The need to move from 6-minute walk distance to outcome trials in pulmonary arterial hypertension
Sean Gaine, Gérald Simonneau
European Respiratory Review Dec 2013, 22 (130) 487-494; DOI: 10.1183/09059180.00006213
Reddit logo Technorati logo Twitter logo Connotea logo Facebook logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
    • Introduction
    • Relationship between 6MWD and long-term outcomes
    • Use of a composite primary end-point consisting of morbidity and mortality events as an alternative to 6MWD
    • Conclusions
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Subjects

  • Pulmonary pharmacology and therapeutics
  • Pulmonary vascular disease
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Role of air pollutants in airway epithelial barrier dysfunction
  • E-cigarettes and nicotine abstinence
  • Lung imaging in cystic fibrosis
Show more Review

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERR

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising
  • Sponsorship

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN: 0905-9180
Online ISSN: 1600-0617

Copyright © 2023 by the European Respiratory Society